Christopher C Goodnow holds The Bill and Patricia Ritchie Foundation Chair as Head of the Immunogenomics Laboratory at the Garvan Institute of Medical Research, and is Professor in the Cellular Genomics Futures Institute and School of Biomedical Sciences at UNSW Sydney. He trained in veterinary medicine and surgery, immunochemistry, and immunology at Sydney University and in DNA technology and molecular immunology at Stanford University. Previous faculty positions were HHMI Investigator at Stanford University, founding Director of the Australian Phenomics Facility at the Australian National University, and Executive Director of the Garvan Institute. Prof. Goodnow's team discovered the immune tolerance checkpoints controlling antibody production, which prevent autoimmune disease and target antibodies against foreign infections. Chris Goodnow's awards include: The Crafoord Prize, Royal Swedish Academy of Sciences; AAI BioLegend Herzenberg Award and Distinguished Fellow, American Association of Immunologists; William E. Paul Award; GSK Award for Research Excellence; Ramaciotti Medal; Health Minister’s Prize; Centenary Medal; Gottschalk Medal; past President and Burnet Orator of the Australian & New Zealand Society for Immunology. He is a Fellow of the Australian Academy of Science, Fellow of the Royal Society, and Member of the US National Academy of Sciences.

Seminar topic: Autoantibodies: how B cell tolerance breaks and resists rituximab treatment